基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 分析化学 标准品 药典标准品和杂质标准品 托法替尼相关化合物 优势供应 托法替尼系列杂质 Tofacitinib Related Compoun
  • 优势供应 托法替尼系列杂质 Tofacitinib Related Compoun

优势供应 托法替尼系列杂质 Tofacitinib Related Compoun

Tofacitinib Related Compoun
广东 更新日期:2023-12-08

深圳瑞恺德生物科技有限公司

非会员
联系人:林小姐
电话:0755-61348847拨打
手机:17820674378 拨打
邮箱:elita.lin@real-chemstandards.com

产品详情:

中文名称:
优势供应 托法替尼系列杂质 Tofacitinib Related Compoun
英文名称:
Tofacitinib Related Compoun
CAS号:
1206824-85-2
品牌:
瑞恺德
产地:
国产
保存条件:
2-8℃
纯度规格:
95%+

1.托法替尼柠檬酸盐

Tofacitinib Citrate

CAS No. 540737-29-9

C16H20N6O. C6H8O7 M.W. 312.38 192.13

 

2.氘代托法替尼柠檬酸盐

Tofacitinib-d3 Citrate

CAS No. 540737-29-9 (non-labelled)

C16H17N6OD3. C6H8O7 M.W. 315.40 192.13

 

3.托法替尼杂质A

Tofacitinib Impurity A

CAS No. 1092578-46-5

C16H20N6O M.W. 312.38

 

 

4.托法替尼杂质B

Tofacitinib Impurity B

CAS No. 1092578-48-7

C16H20N6O M.W. 312.38

 

5.柠檬酸盐托法替尼杂质C

Tofacitinib Impurity C Citrate

CAS No. 1092578-47-6 (free base)

C16H20N6O. C6H8O7 M.W. 312.38 192.13

 

6.柠檬酸盐托法替尼杂质

Citrate     Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R))

CAS No. N/A

C13H19N5 M.W. 245.33

 

 

7.托法替尼杂质

Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3R,4S))

CAS No. N/A

C13H19N5 M.W. 245.33

 

8.N-羟基托法替尼杂质

Tofacitinib N-hydroxy Impurity

CAS No. N/A

C13H19N5O M.W. 261.33

 

9.托法替尼相关物质1

Tofacitinib related compound 1

C16H22N6O2 M.W. 330.39

 

 

10.盐酸托法替尼相关物质2

Tofacitinib Related Compound 2 HCl

CAS No. 1629858-78-1 (free base)

C10H17N3O. HCl M.W. 195.27 36.46

 

11.托法替尼相关物质3

Tofacitinib Related Compound 3

C13H18N4O2 M.W. 262.31

 

 

12.托法替尼相关物质4

Tofacitinib related compound 4

C16H20N6O M.W. 312.38

 

13.托法替尼相关物质5

Tofacitinib related compound 5

C13H19N5 M.W. 245.33

 

14.托法替尼相关物质6

Tofacitinib Related Compound 6

C19H21N7O2 M.W. 379.42

 

15.托法替尼相关物质8

Tofacitinib Related Compound 8

C29H38N10O2 M.W. 558.69

 

 

16.托法替尼相关物质9

Tofacitinib Related Compound 9

C34H45N7 M.W. 551.78

 

17.托法替尼相关物质10

Tofacitinib Related Compound 10

C13H19N5 M.W. 245.33

 

18.托法替尼相关杂质(PF-05579970)

Tofacitinib Related Impurity (PF-05579970)

CAS No. N/A

C15H21N5O M.W. 287.37

 

 

19.消旋托法替尼杂质

rac-Tofacitinib (Mixture of Diastereomers)

CAS No. 344418-92-4

C16H20N6O M.W. 312.38

 

20.托法替尼杂质F

Tofacitinib Impurity F

CAS No. 384338-23-2

C14H22N2 M.W. 218.34

 

21.托法替尼杂质I

Tofacitinib Impurity I

CAS No. N/A

C14H22N2 2HCl M.W. 218.34 2x36.46

 

 

22.托法替尼杂质J

Tofacitinib Impurity J

CAS No. N/A

C14H22N2 2HCl M.W. 218.34 2x36.46

 

23.托法替尼杂质K

Tofacitinib Impurity K

CAS No. N/A

C16H21N5O3 M.W. 331.38

 

24.托法替尼杂质L

Tofacitinib Impurity L

CAS No. 1675248-19-7

C16H22N6O2 M.W. 330.39

 

 

25.托法替尼杂质M

Tofacitinib Impurity M

CAS No. 477600-74-1

C13H19N5 M.W. 245.33

 

26.托法替尼杂质N

Tofacitinib Impurity N

CAS No. 1260614-73-0

C13H19N5 M.W. 245.33

 

27.托法替尼杂质O

Tofacitinib Impurity O

CAS No. N/A

C20H25N5 M.W. 335.46

 

 

28.托法替尼杂质P

Tofacitinib Impurity P

CAS No. 1252883-90-1

C20H25N5 M.W. 335.46

 

29.托法替尼杂质Q

Tofacitinib Impurity Q

CAS No. 3680-69-1

C6H4ClN3 M.W. 153.57

 

30.托法替尼杂质R

Tofacitinib Impurity R

CAS No. 479633-63-1

C13H10ClN3O2S M.W. 307.76

 

 

31.托法替尼相关物质22

Tofacitinib Related Compound 22

C27H31N5O2S M.W. 489.64

 

32.托法替尼杂质T

Tofacitinib Impurity T

CAS No. N/A

C16H18N6O M.W. 310.36

 

33.托法替尼杂质U

Tofacitinib Impurity U

CAS No. N/A

C13H18ClN5 M.W. 297.77

 

 

34.托法替尼杂质V

Tofacitinib Impurity V

CAS No. N/A

C16H19ClN6O M.W. 346.82

 

35.托法替尼杂质W

Tofacitinib Impurity W

CAS No. N/A

C13H18ClN5 M.W. 279.77

 

36.托法替尼杂质X

Tofacitinib Impurity X

CAS No. N/A

C13H19N5 M.W. 245.33

 

 

37.托法替尼杂质Y

Tofacitinib Impurity Y

CAS No. N/A

C14H21N5 M.W. 259.36

 

38.托法替尼杂质Z

Tofacitinib Impurity Z

CAS No. 477600-76-3

C15H21N5O M.W. 287.37

 

39.托法替尼相关物质11

Tofacitinib Related Compound 11

CAS No. 1640971-60-3

C14H20N6O M.W. 288.36

 

 

40.托法替尼相关物质12

Tofacitinib Related Compound 12

CAS No. N/A

C20H25N5 M.W. 335.46

 

41.托法替尼相关物质13

Tofacitinib Related Compound 13

CAS No. N/A

C20H25N5 M.W. 335.46

 

42.托法替尼相关物质14

Tofacitinib Related Compound 14

CAS No. N/A

C14H19N5O M.W. 273.34

 

 

43.托法替尼相关物质15

Tofacitinib Related Compound 15

C15H21N5O M.W. 287.37

 

44.托法替尼相关物质16

Tofacitinib Related Compound 16

C15H23N5 M.W. 273.38

 

45.托法替尼相关物质17

Tofacitinib Related Compound 17

C27H31N5O2S M.W. 489.64

 

 

46.托法替尼相关物质18

Tofacitinib Related Compound 18

C27H31N5O2S M.W. 489.64

 

47.托法替尼相关物质19

Tofacitinib Related Compound 19

C16H20N6O2 M.W. 328.38

 

48.托法替尼相关物质20

Tofacitinib Related Compound 20

C23H26N6O3S M.W. 466.57

 

 

49.托法替尼相关物质21

Tofacitinib Related Compound 21

CAS No. 1640972-35-5

C16H22N6O M.W. 314.39

 

50.托法替尼相关物质23

Tofacitinib Related Compound 23 DiHCl

CAS No. 1812890-23-5 (free base)

C13H21N5.2 HCl M.W. 247.35 2 36.46

 

51.托法替尼相关物质24

Tofacitinib Related Compound 24

C19H23N7O2 M.W. 381.44

 

 

52.托法替尼相关物质25

Tofacitinib Related Compound 25

C27H31N5OS M.W. 473.65

 

53.托法替尼相关物质26

Tofacitinib Related Compound 26 HCl

CAS No. 1206824-85-2

C10H17N3O. HCl M.W. 195.27 36.46

 

54.托法替尼相关物质27

Tofacitinib Related Compound 27

C13H18N4O2 M.W. 262.31

 

55.托法替尼相关物质28

Tofacitinib Related Compound 28 (rac-trans-Tofacitinib)

C16H20N6O M.W. 312.38

 

56.托法替尼相关物质29

Tofacitinib Related Compound 29

C6H6ClN3 M.W. 155.59

 

57.托法替尼相关物质30

Tofacitinib Related Compound 30

C20H27N5 M.W. 337.47

 

 

58.托法替尼相关物质31

Tofacitinib Related Compound 31

C12H7ClN6 M.W. 270.68

 

59.托法替尼相关物质32

Tofacitinib Related Compound 32

C23H31N7O3 M.W. 453.55

 

60.托法替尼相关物质33

Tofacitinib Related Compound 33

C32H40N12O2 M.W. 624.75

 

 

61.托法替尼相关物质34

Tofacitinib Related Compound 34

C20H26ClN5 M.W. 371.91

 

62.托法替尼相关物质35

Tofacitinib Related Compound 35

C21H27N7O3 M.W. 425.49

 

63.托法替尼相关物质36

Tofacitinib Related Compound 36

C21H27N7O3 M.W. 425.49

 

 

64.托法替尼相关物质37

Tofacitinib Related Compound 37

C33H41N11O2 M.W. 623.77

 

65.托法替尼相关物质38

Tofacitinib Related Compound 38

CAS No. 477600-69-4

C14H22N2 M.W. 218.34

 

66.托法替尼相关物质39

Tofacitinib Related Compound 39

C27H31N5O2S M.W. 489.64

 

 

67.托法替尼相关物质40

Tofacitinib Related Compound 40

C20H29N5O3 M.W. 387.48

 

68.托法替尼相关物质41

Tofacitinib Related Compound 41

C23H31N7O3 M.W. 453.55

 

69.托法替尼相关物质42

Tofacitinib Related Compound 42

C19H22N8 M.W. 362.44

 

 

70.托法替尼相关物质43

Tofacitinib Related Compound 43

C14H22N2O M.W. 234.34

 

 

71.托法替尼相关物质

2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

CAS No. 90213-66-4

C6H3Cl2N3 M.W. 188.01

 

 

72.托法替尼相关物质44

Tofacitinib Related Compound 44

C14H22N2. C20H18O8 M.W. 218.34 386.36

 

73.托法替尼相关物质45

Tofacitinib Related Compound 45

C20H24ClN5 M.W. 369.90

 

74.托法替尼相关物质46

Tofacitinib Related Compound 46

C14H22N2. C20H18O8 M.W. 218.34 386.36

 

 

75.托法替尼相关物质47

Tofacitinib Related Compound 47

C14H22N2. C20H18O8 M.W. 218.34 386.36

 

76.托法替尼相关物质48

Tofacitinib Related Compound 48

C14H22N2. C20H18O8 M.W. 218.34 386.36

 

77.托法替尼相关物质49

Tofacitinib Related Compound 49

C20H24ClN5 M.W. 369.90

 

产品名称:托法替尼杂质

规格:10/25/50/100mg

备注:现货,提供COA/HNMR/MS/HPLC

报价:需咨询,可带17%增值税发票或3%普通发票

到货方式:顺丰快递,款到当天发货,国内2-4天到货

付款方式:可协商(预付款等方式)

用途:托法替尼系列杂质,用于托法替尼药物研究中有关物质研究和检查。提供详细的结构确证图,含量标定图谱和详细的质量证书

托法替尼系列杂质;Tofacitinib Related Compound ;1206824-85-2

公司简介

深圳瑞恺德生物科技有限公司是一家集医药行业标准品及杂质对照研发、生产、销售为一体的高科技企业。公司研发生产部门设在湖南长沙高新开发区,主要提供原料药(API)、医药中间体、药物杂质标准品、生化试剂的开发和生产,并承接难度较高的杂质对照品定制合成及项目研发服务;销售总部设在深圳福田区,主要提供进口标准品,对照品,分析试剂,原研参比制剂,借助毗邻香港的优势,可以实现国外药品、标准品和杂质对照品快速通关。瑞恺德生物科技致力于为医药科学研究领域提供优质产品和服务。自公司成立以来,公司提供的新药技术转让项目达到10余个,标准品、对照品、分析试剂产品300,000余种,与全球众多知名的试剂公司、药企、研发机构及高校等建

成立日期 (8年)
注册资本 100.000000万人民币
员工人数 1-10人
年营业额 ¥ 500万-1000万
经营模式 贸易
主营行业 分析化学,标准品和对照品

优势供应 托法替尼系列杂质 Tofacitinib Related Compoun相关厂家报价

内容声明
拨打电话 立即询价